Protein-RNA interactions (PRIs) control pivotal steps in RNA biogenesis, regulate multiple physiological and pathological cellular networks, and are emerging as important drug targets. However, targeting of specific protein-RNA interactions for therapeutic developments is still poorly advanced. Studies and manipulation of these interactions are technically challenging and in vitro drug screening assays are often hampered due to the complexity of RNA structures. The binding of nucleolin (NCL) to a G-quadruplex (G4) structure in the messenger RNA (mRNA) of the Epstein-Barr virus (EBV)-encoded EBNA1 has emerged as an interesting therapeutic target to interfere with immune evasion of EBV-associated cancers. Using the NCL-EBNA1 mRNA interaction as a model, we describe a quantitative proximity ligation assay (PLA)-based in cellulo approach to determine the structure activity relationship of small chemical G4 ligands. Our results show how different G4 ligands have different effects on NCL binding to G4 of the EBNA1 mRNA and highlight the importance of in-cellulo screening assays for targeting RNA structure-dependent interactions.

Chemistry Modelling and Imaging for Biology CNRS UMR9187 Inserm U1196 Institut Curie Université Paris Sud F 91405 Orsay France

Department of Medical Biosciences Umeå University 90187 Umeå Sweden

GGB Université de Brest Inserm CHRU Brest EFS UMR 1078 F 29200 Brest France

ICCVS University of Gdańsk Science ul Wita Stwosza 63 80 308 Gdańsk Poland

RECAMO Masaryk Memorial Cancer Institute Zluty kopec 7 65653 Brno Czech Republic

Université Paris 7 Inserm UMR 1162 75013 Paris France

Zobrazit více v PubMed

Beckmann B.M., Castello A., Medenbach J. The expanding universe of ribonucleoproteins: Of novel RNA-binding proteins and unconventional interactions. Pflugers Arch. 2016;468:1029–1040. doi: 10.1007/s00424-016-1819-4. PubMed DOI PMC

Bao H.L., Ishizuka T., Sakamoto T., Fujimoto K., Uechi T., Kenmochi N., Xu Y. Characterization of human telomere RNA G-quadruplex structures in vitro and in living cells using 19F NMR spectroscopy. Nucleic Acids Res. 2017;45:5501–5511. doi: 10.1093/nar/gkx109. PubMed DOI PMC

Bao H.L., Xu Y. Investigation of higher-order RNA G-quadruplex structures in vitro and in living cells by (19)F NMR spectroscopy. Nat. Protoc. 2018;13:652–665. doi: 10.1038/nprot.2017.156. PubMed DOI

Haeusler A.R., Donnelly C.J., Periz G., Simko E.A., Shaw P.G., Kim M.S., Maragakis N.J., Troncoso J.C., Pandey A., Sattler R., et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195–200. doi: 10.1038/nature13124. PubMed DOI PMC

Taylor J.P. Neurodegenerative diseases: G-quadruplex poses quadruple threat. Nature. 2014;507:175–177. doi: 10.1038/nature13067. PubMed DOI

Wolfe A.L., Singh K., Zhong Y., Drewe P., Rajasekhar V.K., Sanghvi V.R., Mavrakis K.J., Jiang M., Roderick J.E., Van der Meulen J., et al. RNA G-quadruplexes cause eIF4a-dependent oncogene translation in cancer. Nature. 2014;513:65–70. doi: 10.1038/nature13485. PubMed DOI PMC

Largy E., Granzhan A., Hamon F., Verga D., Teulade-Fichou M.P. Visualizing the quadruplex: From fluorescent ligands to light-up probes. Top Curr. Chem. 2013;330:111–177. PubMed

Mendoza O., Bourdoncle A., Boule J.B., Brosh R.M., Jr., Mergny J.L. G-quadruplexes and helicases. Nucleic Acids Res. 2016;44:1989–2006. doi: 10.1093/nar/gkw079. PubMed DOI PMC

Song J., Perreault J.P., Topisirovic I., Richard S. RNA G-quadruplexes and their potential regulatory roles in translation. Translation (Austin) 2016;4 doi: 10.1080/21690731.2016.1244031. PubMed DOI PMC

Lista M.J., Martins R.P., Angrand G., Quillevere A., Daskalogianni C., Voisset C., Teulade-Fichou M.P., Fahraeus R., Blondel M. A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness. Microb. Cell. 2017;4:305–307. doi: 10.15698/mic2017.09.590. PubMed DOI PMC

Lista M.J., Martins R.P., Billant O., Contesse M.A., Findakly S., Pochard P., Daskalogianni C., Beauvineau C., Guetta C., Jamin C., et al. Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA. Nat. Commun. 2017;8 doi: 10.1038/ncomms16043. PubMed DOI PMC

De Cian A., Delemos E., Mergny J.L., Teulade-Fichou M.P., Monchaud D. Highly efficient G-quadruplex recognition by bisquinolinium compounds. J. Am. Chem. Soc. 2007;129:1856–1857. doi: 10.1021/ja067352b. PubMed DOI

Yin Y., Manoury B., Fahraeus R. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science. 2003;301:1371–1374. doi: 10.1126/science.1088902. PubMed DOI

Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 2012;9:671–675. doi: 10.1038/nmeth.2089. PubMed DOI PMC

Murat P., Zhong J., Lekieffre L., Cowieson N.P., Clancy J.L., Preiss T., Balasubramanian S., Khanna R., Tellam J. G-quadruplexes regulate Epstein-Barr virus-encoded Nuclear Antigen 1 mRNA translation. Nat. Chem. Biol. 2014;10:358–364. doi: 10.1038/nchembio.1479. PubMed DOI PMC

Soderberg O., Gullberg M., Jarvius M., Ridderstrale K., Leuchowius K.J., Jarvius J., Wester K., Hydbring P., Bahram F., Larsson L.G., et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods. 2006;3:995–1000. doi: 10.1038/nmeth947. PubMed DOI

Gomez D., Shankman L.S., Nguyen A.T., Owens G.K. Detection of histone modifications at specific gene loci in single cells in histological sections. Nat. Methods. 2013;10:171–177. doi: 10.1038/nmeth.2332. PubMed DOI PMC

de Klerk E., t Hoen P.A. Alternative mRNA transcription, processing, and translation: Insights from RNA sequencing. Trends Genet. 2015;31:128–139. doi: 10.1016/j.tig.2015.01.001. PubMed DOI

Mitchell S.F., Parker R. Principles and properties of eukaryotic mRNPs. Mol. Cell. 2014;54:547–558. doi: 10.1016/j.molcel.2014.04.033. PubMed DOI

Daskalogianni C., Pyndiah S., Apcher S., Mazars A., Manoury B., Ammari N., Nylander K., Voisset C., Blondel M., Fahraeus R. Epstein-Barr virus-encoded EBNA1 and ZEBRA: Targets for therapeutic strategies against EBV-carrying cancers. J. Pathol. 2015;235:334–341. doi: 10.1002/path.4431. PubMed DOI

Wilson J.B., Manet E., Gruffat H., Busson P., Blondel M., Fahraeus R. EBNA1: Oncogenic activity, immune evasion and biochemical functions provide targets for novel therapeutic strategies against Epstein-Barr virus-associated cancers. Cancers (Basel) 2018;10:109. doi: 10.3390/cancers10040109. PubMed DOI PMC

Biffi G., Di Antonio M., Tannahill D., Balasubramanian S. Visualization and selective chemical targeting of RNA G-quadruplex structures in the cytoplasm of human cells. Nat Chem. 2014;6:75–80. doi: 10.1038/nchem.1805. PubMed DOI PMC

Hermann T. Strategies for the design of drugs targeting RNA and RNA-protein complexes. Angew. Chem. Int. Ed. Engl. 2000;39:1890–1904. doi: 10.1002/1521-3773(20000602)39:11<1890::AID-ANIE1890>3.0.CO;2-D. PubMed DOI

Yangyuoru P.M., Di Antonio M., Ghimire C., Biffi G., Balasubramanian S., Mao H. Dual binding of an antibody and a small molecule increases the stability of terra G-quadruplex. Angew. Chem. Int. Ed. Engl. 2015;54:910–913. doi: 10.1002/anie.201408113. PubMed DOI PMC

Gabelica V., Maeda R., Fujimoto T., Yaku H., Murashima T., Sugimoto N., Miyoshi D. Multiple and cooperative binding of fluorescence light-up probe thioflavin T with human telomere DNA G-quadruplex. Biochemistry. 2013;52:5620–5628. doi: 10.1021/bi4006072. PubMed DOI

Type I arginine methyltransferases are intervention points to unveil the oncogenic Epstein-Barr virus to the immune system

The different activities of RNA G-quadruplex structures are controlled by flanking sequences